- Home
- VERX vs PTGX Comparison
VERX vs PTGX Comparison
Compare VERX & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERX
- PTGX
- Stock Information
- Founded
- VERX 1978
- PTGX 2006
- Country
- VERX United States
- PTGX United States
- Employees
- VERX N/A
- PTGX 130
- Industry
- VERX Computer Software: Prepackaged Software
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- VERX Technology
- PTGX Health Care
- Exchange
- VERX Nasdaq
- PTGX Nasdaq
- Market Cap
- VERX 3.9B
- PTGX 4.0B
- IPO Year
- VERX 2020
- PTGX 2016
- Fundamental
- Price
- VERX $24.86
- PTGX $64.22
- Analyst Decision
- VERX Buy
- PTGX Strong Buy
- Analyst Count
- VERX 14
- PTGX 8
- Target Price
- VERX $41.85
- PTGX $71.13
- AVG Volume (30 Days)
- VERX 1.5M
- PTGX 1.0M
- Earning Date
- VERX 11-03-2025
- PTGX 11-06-2025
- Dividend Yield
- VERX N/A
- PTGX N/A
- EPS Growth
- VERX N/A
- PTGX N/A
- EPS
- VERX N/A
- PTGX 0.80
- Revenue
- VERX $710,512,000.00
- PTGX $209,180,000.00
- Revenue This Year
- VERX $15.07
- PTGX N/A
- Revenue Next Year
- VERX $13.09
- PTGX $248.17
- P/E Ratio
- VERX N/A
- PTGX $80.55
- Revenue Growth
- VERX 15.00
- PTGX N/A
- 52 Week Low
- VERX $23.13
- PTGX $33.31
- 52 Week High
- VERX $60.71
- PTGX $68.26
- Technical
- Relative Strength Index (RSI)
- VERX 47.83
- PTGX 56.23
- Support Level
- VERX $24.30
- PTGX $63.82
- Resistance Level
- VERX $25.47
- PTGX $68.26
- Average True Range (ATR)
- VERX 0.86
- PTGX 2.51
- MACD
- VERX 0.17
- PTGX -0.11
- Stochastic Oscillator
- VERX 37.78
- PTGX 55.94
About VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.